Bradley Foster & Sargent Inc Biogen Inc. Transaction History

Bradley Foster & Sargent Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $186,927 - $215,831	-706 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$220.06 - $304.07 $155,362 - $214,673	706 New	706 $210,000
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $240,271 - $269,487	-1,105 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$219.29 - $241.72 $100,873 - $111,191	-460 Reduced 29.39%	1,105 $258,000
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $378,592 - $592,163	-1,747 Reduced 52.75%	1,565 $370,000
Q4 2018 Jan 30, 2019	SELL	$278.5 - $352.75 $227,813 - $288,549	-818 Reduced 19.81%	3,312 $997,000
Q3 2018 Oct 31, 2018	BUY	$293.51 - $383.83 $28,763 - $37,615	98 Added 2.43%	4,130 $1.46 Million
Q2 2018 Jul 31, 2018	SELL	$257.52 - $306.91 $114,596 - $136,574	-445 Reduced 9.94%	4,032 $1.17 Million
Q1 2018 May 07, 2018	SELL	$260.13 - $367.91 $26,013 - $36,791	-100 Reduced 2.18%	4,477 $1.23 Million
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $13,843 - $15,506	45 Added 0.99%	4,577 $1.46 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $1.27 Million - $1.49 Million	4,532	4,532 $1.42 Million

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.